A systematic review of the versatile effects of the Peruvian Maca Root (Lepidium meyenii ) on sexual dysfunction, menopausal symptoms and related conditions-Reference-Cited by-同舟云学术

A systematic review of the versatile effects of the Peruvian Maca Root (Lepidium meyenii ) on sexual dysfunction, menopausal symptoms and related conditions

Published:2022-11 Issue:4 Volume:2 Page:100326
ISSN:2667-0313
Container-title:Phytomedicine Plus
language:en
Short-container-title:Phytomedicine Plus

Author:

Bower-Cargill Cherie^ORCID,Yarandi Niousha,Petróczi Andrea

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference89 articles.

1. Antidepressant-like behavioral, anatomical, and biochemical effects of petroleum ether extract from maca ( Lepidium meyenii ) in mice exposed to chronic unpredictable mild stress;Ai;J. Med. Food,2014

2. The flaws and human harms of animal experimentation. Cambridge quarterly of healthcare ethics;Akhtar;Camb. Q. Healthc. Ethics,2015

3. The Pure Power of Maca;Bennett,2016

4. Effects of maca (lepidium meyenii walp) powder on serum indices and metabolic responses in racehorses;Bilal;J. Anim. Plant Sci.,2016

5. Herbal dietary supplements for erectile dysfunction: a systematic review and meta-analysis;Borrelli;Drugs,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Gelatinized Maca on Andropause Symptoms in Aged Male Mice;International Journal of Pharmacology;2024-05-01

2. UPLC-TQD-MS/MS Method Validation for Quality Control of Alkaloid Content in Lepidium meyenii (Maca)-Containing Food and Dietary Supplements;ACS Omega;2024-03-26

3. Not All Maca Is Created Equal: A Review of Colors, Nutrition, Phytochemicals, and Clinical Uses;Nutrients;2024-02-14

4. Short-term effects and safety of a natural oral supplement containing glucosinolates, phytosterols, and citrus flavonoids compared with hormone treatment for the management of postmenopausal symptomatic women: a pilot single-center randomized phase 2 clinical trial;Menopause;2023-10-24